|
ZFYVE26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.773200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.518800E-01 |
| Normal-vs-Stage2 |
2.945400E-01 |
| Normal-vs-Stage3 |
2.176400E-03 |
| Normal-vs-Stage4 |
1.119970E-02 |
| Stage1-vs-Stage2 |
7.175500E-02 |
| Stage1-vs-Stage3 |
1.52264999999652E-05 |
| Stage1-vs-Stage4 |
3.573000E-04 |
| Stage2-vs-Stage3 |
2.419600E-01 |
| Stage2-vs-Stage4 |
2.657400E-01 |
| Stage3-vs-Stage4 |
7.875600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.548970E-01 |
| Normal-vs-AfricanAmerican |
6.466400E-01 |
| Normal-vs-Asian |
3.149400E-01 |
| Caucasian-vs-AfricanAmerican |
2.237400E-01 |
| Caucasian-vs-Asian |
6.276500E-02 |
| AfricanAmerican-vs-Asian |
3.318200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.110450E-01 |
| Normal-vs-Female |
9.735800E-01 |
| Male-vs-Female |
1.027180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.255800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.815800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.164100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.014760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.375800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.462000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.839800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.709830E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.106790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.129600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.337600E-03 |
| Normal-vs-Grade 2 |
8.171200E-01 |
| Normal-vs-Grade 3 |
1.012810E-01 |
| Normal-vs-Grade 4 |
1.401500E-03 |
| Grade 1-vs-Grade 2 |
1.993550E-04 |
| Grade 1-vs-Grade 3 |
1.6015799999991E-05 |
| Grade 1-vs-Grade 4 |
3.16499999997166E-06 |
| Grade 2-vs-Grade 3 |
4.416400E-02 |
| Grade 2-vs-Grade 4 |
2.585200E-04 |
| Grade 3-vs-Grade 4 |
2.524100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.914400E-01 |
| Normal-vs-ccB subtype |
1.206980E-01 |
| ccA subtype-vs-ccB subtype |
1.305710E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.252000E-01 |
| Normal-vs-N1 |
2.707800E-02 |
| N0-vs-N1 |
3.962000E-02 |
|
|
